ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNOA Sonoma Pharmaceuticals Inc

0.155
-0.0016 (-1.02%)
After Hours
Last Updated: 19:49:03
Delayed by 15 minutes

Period:

Draw Mode:

Volume 166,482
Bid Price 0.1481
Ask Price 0.155
News -
Day High 0.1597

Low
0.1159

52 Week Range

High
1.52

Day Low 0.148
Company Name Stock Ticker Symbol Market Type
Sonoma Pharmaceuticals Inc SNOA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0016 -1.02% 0.155 19:49:03
Open Price Low Price High Price Close Price Prev Close
0.148 0.148 0.1597 0.15 0.1566
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
442 166,482 $ 0.1525494 $ 25,397 - 0.1159 - 1.52
Last Trade Time Type Quantity Stock Price Currency
17:18:22 formt 255 $ 0.155 USD

Sonoma Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.34M 15.61M - 13.27M -5.15M -0.33 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sonoma Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SNOA Message Board. Create One! See More Posts on SNOA Message Board See More Message Board Posts

Historical SNOA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.1740.1850.1480.1690162327,665-0.019-10.92%
1 Month0.13220.19190.13220.1615517845,7900.022817.25%
3 Months0.16620.31080.13110.17463331,535,877-0.0112-6.74%
6 Months0.76650.76650.11590.18768471,536,841-0.6115-79.78%
1 Year0.9741.520.11590.3636651905,088-0.819-84.09%
3 Years8.6513.360.11593.33925,547-8.50-98.21%
5 Years0.8719.540.11594.37682,070-0.715-82.18%

Sonoma Pharmaceuticals Description

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.

Your Recent History

Delayed Upgrade Clock